Fenofibrate

   
Google
 
Web NewDrugInformation.com

Fenofibrate


Drug - Fenofibrate
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Fenofibrate
Multiple ingredients are in alphabetical order.

Strength - 54MG
The potency of the active ingredient(s), Fenofibrate. May repeat for multiple part products.

Applicant - RANBAXY
The firm name holding legal responsibility for Fenofibrate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076635
The FDA assigned number to Fenofibrate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Fenofibrate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 31, 2005
The date Fenofibrate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Fenofibrate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Fenofibrate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ranbaxy Laboratories Ltd
The full name of the firm holding legal responsibility for the new application of Fenofibrate.

Fenofibrate